Cargando…
A Novel Chimeric Antigen as a Vaccine Candidate against Leishmania major: In silico Analysis
BACKGROUND: Leishmania is a mandatory intracellular pathogen and causing neglected disease. Hence, protection against leishmaniasis by a development vaccine is an important subject. This study aimed to design a poly-epitope vaccine for cutaneous leishmaniasis. METHODS: The present study was conducte...
Autores principales: | Ahmadpour, Niloofar Bavarsad, Dalimi, Abdolhossein, Pirestani, Majid, Sadraei, Javid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418661/ https://www.ncbi.nlm.nih.gov/pubmed/34557233 http://dx.doi.org/10.18502/ijpa.v16i2.6267 |
Ejemplares similares
-
In silico analysis and expression of a new chimeric antigen as a vaccine candidate against cutaneous leishmaniasis
por: Motamedpour, Leila, et al.
Publicado: (2020) -
In-vitro and In-vivo Antileishmanial Activity of a Compound Derived of Platinum, Oxaliplatin, against Leishmania Major
por: Ghasemi, Ezatollah, et al.
Publicado: (2019) -
In vitro and in vivo antileishmanial effects of aloe-emodin on Leishmania major
por: Dalimi, Abdolhossein, et al.
Publicado: (2015) -
High occurrence of Blastocystis sp. subtype 3 in individuals referred to medical laboratories in Kermanshah, Iran
por: Maleki, Bahman, et al.
Publicado: (2022) -
In vitro anti-gastrointestinal cancer activity of Toxocara canis
-derived peptide: Analyzing the expression level of factors related to cell proliferation and tumor growth
por: Bahadory, Saeed, et al.
Publicado: (2022)